Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma.
Zaki
Mohamed
M
Pediatric Department, Farwania Hospital, Safat, Kuwait.
Schöneberg
Torsten
T
Al Ajrawi
Tareq
T
Al Said
Abdul Nasser
AN
Sangkuhl
Katrin
K
Römpler
Holger
H
D000595:Amino Acid Sequence; D051399:Aquaporin 2 / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000601:surgery*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D018500:Diabetes Insipidus, Nephrogenic / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007231:Infant, Newborn; D007680:Kidney Neoplasms / Q000601:surgery*; D008297:Male; D008969:Molecular Sequence Data; D017386:Sequence Homology, Amino Acid; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
C496023:AQP2 protein, human; D051399:Aquaporin 2; D002317:Cardiovascular Agents; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D007213:Indomethacin